Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07820748

Linear Piezoelectric Low Intensity Shockwave Treatment (LI-SWT) for the Treatment of Erectile Dysfunction in PDE5i Non Responder

Conditions: Erectile Dysfunction

Sex: Male
Ages: 30 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 40
Sponsor: The University of Hong Kong

Location: Queen Mary Hospital Hong Kong

Summary

The goal of this clinical trial is to assess the efficacy and safety of linear piezoelectric Li-SWT for erectile dysfunction patients who have poor treatment respond from PDE5i oral treatment. Participants will be randomised to either receive 4 cycles, once per week, of Li-SWT treatment on the penis or the Sham group, where the treatment appears to be identical but the shockwave machine is deactivated. Investigators will compare the before and after treatment erectile function using the IIEF questionnaire of the two groups 1 month after treatment to assess the treatment outcome. After that, the Sham group patient would be offered to receive compensatory Li-SWT treatment and their post treatment response will be assessed. All the patients completing the Li-SWT treatment will be followed up at 6 and 12 months to assess the efficacy and adverse events.

Eligibility Criteria

Inclusion Criteria: * Male * Age 30-80 years * ED for at least 6 months, defined by IIEF-EF score 8-21 (moderate - mild) * Sexually active in a stable, heterosexual relationship of more than 3 months duration. * Agree to comply with all study related tests/procedures * Morning serum testosterone \>12nmol/L * Inadequate response after at least 4 attempts using highest tolerated PDE5i Exclusion Criteria: * Previous penile surgery (e.g. penile lengthening, penile cancer surgery, penile plication, grafting, penile implant). * Previous history of priapism or penile fracture * Morning serum testosterone level \1.5 (Patients on aspirin are eligible) 7 * Current or prior history of sexually transmitted disease * Tumor tissue/Treatment for cancer in the penile or pelvic region in past 5 years * Electronic devices implanted in the body (e.g. cardiac pacemaker, deep brain stimulator, spinal cord neurostimulator etc.) * Any other medical conditions or medical history that are deemed unsafe or high risk for the study treatment per investigator's discretion

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07820748). StuddyBuddy aggregates publicly available trial information.